Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Slovenia

Drug Market Growth To Stay Positive Despite Price Cutting Moves

April 2012 | Industry Trend Analysis

BMI View: Our view that Slovenia's drug market is one of the most stable in the region remains in place despite the fact that at the start of 2012 the government introduced new measures to control public drug expenditure. Its methods are considerably less aggressive than those in other Central and Eastern European markets.

To read the full article, please choose one of the following options:

Subcribers please log in

Emerging Europe InsightEmerging Europe Channels Emerging Europe Countries